Sara Pharm Solutions Competitors and Similar CompaniesClear all

Delta-Fly Pharma's competitors and similar companies include Impel Pharmaceuticals.
Delta-Fly Pharma
Delta-Fly Pharma
Delta-Fly Pharma 株式会社(デルタフライファーマ is a manufacturer and seller of anti-cancer agents and other products.
Impel Pharmaceuticals
Impel Pharmaceuticals
Impel Pharmaceuticals (formerly known as Impel NeuroPharma) is a pharmaceutical company that develops and commercializes therapies for patients suffering from central nervous system diseases.
Founding Date
Founding Date
2010
Founding Date
2008
Type
Type
Public
Type
Public
Tags
Locations
Locations
HQ
Locations
Seattle, US HQ
Employees
Employees
N/A
Employees
6710% increase
Valuation ($)
Valuation ($)
29.5 m
Valuation ($)
5.8 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$12.7m (FY, 2022)
Cost of goods
Cost of goods
(¥1.4m) (FY, 2026)
Cost of goods
$6.5m (FY, 2022)
Gross profit
Gross profit
¥1.4m (FY, 2026)
Gross profit
$6.2m (FY, 2022)
Net income
Net income
(¥1.6b) (FY, 2026)
Net income
($106.3m) (FY, 2022)
For sources of this data, please see the company profile

View Company Profiles

Impel Pharmaceuticals
HQ
Seattle, US
Employees
67↑ 10% increase

Impel Pharmaceuticals (formerly known as Impel NeuroPharma) is a pharmaceutical company that develops and commercializes therapies for patients suffering from central nervous system diseases.

View company